福瑞达: 国浩律师（济南）事务所关于鲁商福瑞达医药股份有限公司2024年年度股东大会之法律意见书

Group 1 - The legal opinion letter was issued by Grandall Law Firm (Jinan) regarding the 2024 annual general meeting of Shandong Ruyuan Pharmaceutical Co., Ltd. [1][2] - The law firm confirmed that it conducted thorough verification and ensured that the facts presented in the legal opinion are true, accurate, and complete [2][3] - The meeting was convened by the company's board of directors and announced through various channels, complying with legal requirements [3][4] Group 2 - The meeting was held on June 25, 2025, and utilized a combination of on-site and online voting methods [4][5] - A total of 11 shareholders attended the meeting, representing 557,057,233 shares, which accounted for 54.7978% of the total voting shares [5][6] - The voting results showed that all proposed resolutions were approved, with significant support from minority shareholders [6]